Figure 5From: Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis Effect of LAM + ADV vs. ETV at 48 weeks on biochemical response. Back to article page